Literature DB >> 17372013

Recognition of double-stranded RNA by TLR3 induces severe small intestinal injury in mice.

Rongbin Zhou1, Haiming Wei, Rui Sun, Zhigang Tian.   

Abstract

The role of TLRs on intestinal epithelial cells (IECs) is controversial, and the mechanisms by which TLRs influence mucosal homeostasis are obscure. In this study, we report that genomic dsRNA from rotavirus, and its synthetic analog polyinosinic-polycytidylic acid (poly(I:C)), induce severe mucosal injury in the small intestine. Upon engaging TLR3 on IECs, dsRNA triggers IECs to secrete IL-15, which functions to increase the percentage of CD3+NK1.1+ intestinal intraepithelial lymphocytes (IELs) and enhances the cytotoxicity of IELs. Moreover, The CD3+NK1.1+ IELs are proved as CD8alphaalpha+ IELs. These results provide direct evidence that abnormal TLR3 signaling contributes to breaking down mucosal homeostasis and the first evidence of pathogenic effects mediated by CD8alphaalpha+ IELs. The data also suggest that genomic dsRNA may be involved in the pathogenesis of acute rotavirus gastroenteritis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372013     DOI: 10.4049/jimmunol.178.7.4548

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  NKG2D recognition mediates Toll-like receptor 3 signaling-induced breakdown of epithelial homeostasis in the small intestines of mice.

Authors:  Rongbin Zhou; Haiming Wei; Rui Sun; Jian Zhang; Zhigang Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

2.  Toll-like receptor and innate cytokine responses induced by lactobacilli colonization and human rotavirus infection in gnotobiotic pigs.

Authors:  Ke Wen; Marli S P Azevedo; Ana Gonzalez; Wei Zhang; Linda J Saif; Guohua Li; Ahmed Yousef; Lijuan Yuan
Journal:  Vet Immunol Immunopathol       Date:  2008-10-31       Impact factor: 2.046

Review 3.  Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory.

Authors:  Avi Levin; Oren Shibolet
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

4.  Immunobiotic Lactobacillus strains reduce small intestinal injury induced by intraepithelial lymphocytes after Toll-like receptor 3 activation.

Authors:  Asuka Tada; Hortensia Zelaya; Patricia Clua; Susana Salva; Susana Alvarez; Haruki Kitazawa; Julio Villena
Journal:  Inflamm Res       Date:  2016-06-09       Impact factor: 4.575

Review 5.  Innate immune signalling at the intestinal epithelium in homeostasis and disease.

Authors:  Johanna Pott; Mathias Hornef
Journal:  EMBO Rep       Date:  2012-07-17       Impact factor: 8.807

Review 6.  Using Diverse Model Systems to Define Intestinal Epithelial Defenses to Enteric Viral Infections.

Authors:  Elisha Segrist; Sara Cherry
Journal:  Cell Host Microbe       Date:  2020-03-11       Impact factor: 21.023

7.  Reovirus-Induced Apoptosis in the Intestine Limits Establishment of Enteric Infection.

Authors:  Judy J Brown; Sarah P Short; Jennifer Stencel-Baerenwald; Kelly Urbanek; Andrea J Pruijssers; Nicole McAllister; Mine Ikizler; Gwen Taylor; Pavithra Aravamudhan; Solomiia Khomandiak; Bana Jabri; Christopher S Williams; Terence S Dermody
Journal:  J Virol       Date:  2018-04-27       Impact factor: 5.103

8.  Activation of TLR3 in the trophoblast is associated with preterm delivery.

Authors:  Kaori Koga; Ingrid Cardenas; Paulomi Aldo; Vikki M Abrahams; Bing Peng; Sara Fill; Roberto Romero; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2009-03       Impact factor: 3.886

9.  A selective role of NKG2D in inflammatory and autoimmune diseases.

Authors:  Nadia Guerra; Kathleen Pestal; Tiffany Juarez; Jennifer Beck; Karen Tkach; Lin Wang; David H Raulet
Journal:  Clin Immunol       Date:  2013-09-14       Impact factor: 3.969

10.  Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3.

Authors:  Dai Iwakiri; Li Zhou; Mrinal Samanta; Misako Matsumoto; Takashi Ebihara; Tsukasa Seya; Shosuke Imai; Mikiya Fujieda; Keisei Kawa; Kenzo Takada
Journal:  J Exp Med       Date:  2009-08-31       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.